Most lately, it's been recognized that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds into a big selection of endogenous opioids. In contrast to most opioid receptors, this receptor functions like a scavenger and does not activate a